{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:58:16Z","timestamp":1740135496074,"version":"3.37.3"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T00:00:00Z","timestamp":1539993600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["274728"],"award-info":[{"award-number":["274728"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006383","name":"Sy\u00f6p\u00e4j\u00e4rjest\u00f6t","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006383","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9liuksen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Turku University Central Hospital"},{"DOI":"10.13039\/501100005609","name":"Turun Yliopisto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005609","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12872-018-0933-y","type":"journal-article","created":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T13:03:42Z","timestamp":1540040622000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Receptor tyrosine kinase profiling of ischemic heart identifies ROR1 as a potential therapeutic target"],"prefix":"10.1186","volume":"18","author":[{"given":"Juho","family":"Heliste","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Jokilammi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilkka","family":"Paatero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepankar","family":"Chakroborty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoffer","family":"Stark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timo","family":"Savunen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Laaksonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5700-0827","authenticated-orcid":false,"given":"Klaus","family":"Elenius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,10,20]]},"reference":[{"key":"933_CR1","volume-title":"Deaths by Cause, Age, Sex, by Country and by Region, 2000-2015","author":"Global Health Estimates 2015","year":"2016","unstructured":"Global Health Estimates 2015. Deaths by Cause, Age, Sex, by Country and by Region, 2000-2015. Geneva: World Health Organization; 2016."},{"issue":"1","key":"933_CR2","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1172\/JCI62874","volume":"123","author":"DJ Hausenloy","year":"2013","unstructured":"Hausenloy DJ, Yellon DM. Myocardial ischemia-reperfusion injury: a neglected therapeutic target. J Clin Invest. 2013;123(1):92\u2013100.","journal-title":"J Clin Invest"},{"issue":"6555","key":"933_CR3","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/378394a0","volume":"378","author":"KF Lee","year":"1995","unstructured":"Lee KF, Simon H, Chen H, Bates B, Hung MC, Hauser C. Requirement for neuregulin receptor erbB2 in neural and cardiac development. Nature. 1995;378(6555):394\u20138.","journal-title":"Nature"},{"issue":"4","key":"933_CR4","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1128\/MCB.22.4.1073-1078.2002","volume":"22","author":"R Chan","year":"2002","unstructured":"Chan R, Hardy WR, Laing MA, Hardy SE, Muller WJ. The catalytic activity of the ErbB-2 receptor tyrosine kinase is essential for embryonic development. Mol Cell Biol. 2002;22(4):1073\u20138.","journal-title":"Mol Cell Biol"},{"issue":"6555","key":"933_CR5","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/378390a0","volume":"378","author":"M Gassmann","year":"1995","unstructured":"Gassmann M, Casagranda F, Orioli D, Simon H, Lai C, Klein R, et al. Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor. Nature. 1995;378(6555):390\u20134.","journal-title":"Nature"},{"issue":"24","key":"933_CR6","doi-asserted-by":"publisher","first-page":"8329","DOI":"10.1128\/MCB.21.24.8329-8335.2001","volume":"21","author":"M Nomi","year":"2001","unstructured":"Nomi M, Oishi I, Kani S, Suzuki H, Matsuda T, Yoda A, et al. Loss of mRor1 enhances the heart and skeletal abnormalities in mRor2-deficient mice: redundant and pleiotropic functions of mRor1 and mRor2 receptor tyrosine kinases. Mol Cell Biol. 2001;21(24):8329\u201335.","journal-title":"Mol Cell Biol"},{"key":"933_CR7","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1046\/j.1365-2443.2000.00300.x","volume":"5","author":"S Takeuchi","year":"2000","unstructured":"Takeuchi S, Takeda K, Oishi I, Nomi M, Ikeya M, Itoh K, et al. Mouse Ror2 receptor tyrosine kinase is required for the heart development and limb formation. Genes Cells. 2000;5:71\u20138.","journal-title":"Genes Cells"},{"key":"933_CR8","doi-asserted-by":"crossref","unstructured":"Munk M, Memon AA, Goetze JP, Nielsen LB, Nexo E, Sorensen BS. Hypoxia Changes the Expression of the Epidermal Growth Factor (EGF) System in Human Hearts and Cultured Cardiomyocytes. Mohanraj R, editor. PLoS One. 2012;7(7):e40243.","DOI":"10.1371\/journal.pone.0040243"},{"issue":"4","key":"933_CR9","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1074\/jbc.M804570200","volume":"284","author":"LI Gordon","year":"2009","unstructured":"Gordon LI, Burke MA, Singh ATK, Prachand S, Lieberman ED, Sun L, et al. Blockade of the erbB2 receptor induces cardiomyocyte death through mitochondrial and reactive oxygen species-dependent pathways. J Biol Chem. 2009;284(4):2080\u20137.","journal-title":"J Biol Chem"},{"issue":"5","key":"933_CR10","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.carpath.2007.04.001","volume":"16","author":"M Infanger","year":"2007","unstructured":"Infanger M, Faramarzi S, Grosse J, Kurth E, Ulbrich C, Bauer J, et al. Expression of vascular endothelial growth factor and receptor tyrosine kinases in cardiac ischemia\/reperfusion injury. Cardiovasc Pathol. 2007;16(5):291\u20139.","journal-title":"Cardiovasc Pathol"},{"issue":"1","key":"933_CR11","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s10534-010-9371-8","volume":"24","author":"K Viswanath","year":"2011","unstructured":"Viswanath K, Bodiga S, Balogun V, Zhang A, Bodiga VL. Cardioprotective effect of zinc requires ErbB2 and Akt during hypoxia\/reoxygenation. Biometals. 2011;24(1):171\u201380.","journal-title":"Biometals"},{"issue":"5","key":"933_CR12","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1161\/01.RES.88.5.513","volume":"88","author":"C Beauloye","year":"2001","unstructured":"Beauloye C, Bertrand L, Krause U, Marsin AS, Dresselaers T, Vanstapel F, et al. No-flow ischemia inhibits insulin signaling in heart by decreasing intracellular pH. Circ Res. 2001;88(5):513\u20139.","journal-title":"Circ Res"},{"issue":"5","key":"933_CR13","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/ncb3149","volume":"17","author":"G D\u2019Uva","year":"2015","unstructured":"D\u2019Uva G, Aharonov A, Lauriola M, Kain D, Yahalom-Ronen Y, Carvalho S, et al. ERBB2 triggers mammalian heart regeneration by promoting cardiomyocyte dedifferentiation and proliferation. Nat Cell Biol. 2015;17(5):627\u201338.","journal-title":"Nat Cell Biol"},{"issue":"2","key":"933_CR14","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.cell.2009.04.060","volume":"138","author":"K Bersell","year":"2009","unstructured":"Bersell K, Arab S, Haring B, K\u00fchn B. Neuregulin1\/ErbB4 signaling induces cardiomyocyte proliferation and repair of heart injury. Cell. 2009;138(2):257\u201370.","journal-title":"Cell"},{"issue":"7","key":"933_CR15","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1016\/j.jacc.2006.05.057","volume":"48","author":"X Liu","year":"2006","unstructured":"Liu X, Gu X, Li Z, Li X, Li H, Chang J, et al. Neuregulin-1\/erbB-activation improves cardiac function and survival in models of ischemic, dilated, and viral cardiomyopathy. J Am Coll Cardiol. 2006;48(7):1438\u201347.","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"933_CR16","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1161\/hh2401.101385","volume":"89","author":"AK Jonassen","year":"2001","unstructured":"Jonassen AK, Sack MN, Mj\u00f8s OD, Yellon DM. Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell-survival signaling. Circ Res. 2001;89(12):1191\u20138.","journal-title":"Circ Res"},{"issue":"9","key":"933_CR17","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1161\/CIRCULATIONAHA.112.130625","volume":"127","author":"AN Grossman","year":"2013","unstructured":"Grossman AN, Opie LH, Beshansky JR, Ingwall JS, Rackley CE, Selker HP. Glucose-insulin-potassium revived: current status in acute coronary syndromes and the energy-depleted heart. Circulation. 2013;127(9):1040\u20138.","journal-title":"Circulation"},{"issue":"9","key":"933_CR18","doi-asserted-by":"publisher","first-page":"R139","DOI":"10.1186\/gb-2008-9-9-r139","volume":"9","author":"Sami Kilpinen","year":"2008","unstructured":"Kilpinen S, Autio R, Ojala K, Iljin K, Bucher E, Sara H, et al. Systematic bioinformatic analysis of expression levels of 17,330 human genes across 9,783 samples from 175 types of healthy and pathological tissues. Genome Biol. 2008;9(9):R139.","journal-title":"Genome Biology"},{"key":"933_CR19","unstructured":"Raivo Kolde (2015). pheatmap: Pretty Heatmaps. R package version 1.0.8. https:\/\/CRAN.R-project.org\/package=pheatmap ."},{"key":"933_CR20","volume-title":"RStudio: integrated development for R","author":"RStudio Team","year":"2016","unstructured":"RStudio Team. RStudio: integrated development for R. Boston, MA: RStudio, Inc.; 2016. http:\/\/www.rstudio.com\/"},{"key":"933_CR21","doi-asserted-by":"crossref","unstructured":"Stark CKJ, Tarkia M, Kentala R, Malmberg M, V\u00e4h\u00e4silta T, Savo M, et al. Systemic dosing of thymosin beta 4 before and after ischemia does not attenuate global myocardial ischemia-reperfusion injury in pigs. Front Pharmacol. 2016;7(115).","DOI":"10.3389\/fphar.2016.00115"},{"issue":"12","key":"933_CR22","doi-asserted-by":"publisher","first-page":"8641","DOI":"10.1074\/jbc.275.12.8641","volume":"275","author":"V Kainulainen","year":"2000","unstructured":"Kainulainen V, Sundvall M, Ma JA, Santiestevan E, Klagsbrun M, Elenius K, et al. A natural ErbB4 isoform that does not activate phosphoinositide 3-kinase mediates proliferation but not survival or chemotaxis. J Biol Chem. 2000;275(12):8641\u20139.","journal-title":"J Biol Chem"},{"issue":"6","key":"933_CR23","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/S0168-9525(00)02024-2","volume":"16","author":"P Rice","year":"2000","unstructured":"Rice P, Longden I, Bleasby A. EMBOSS: the European molecular biology open software suite. Trends Genet. 2000;16(6):276\u20137.","journal-title":"Trends Genet"},{"issue":"1","key":"933_CR24","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc. 1995;57(1):289\u2013300.","journal-title":"J R Stat Soc"},{"issue":"11","key":"933_CR25","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1002\/mc.22426","volume":"55","author":"NB Fern\u00e1ndez","year":"2016","unstructured":"Fern\u00e1ndez NB, Lorenzo D, Picco ME, Barbero G, Dergan-Dylon LS, Marks MP, et al. ROR1 contributes to melanoma cell growth and migration by regulating N-cadherin expression via the PI3K\/Akt pathway. Mol Carcinog. 2016;55(11):1772\u201385.","journal-title":"Mol Carcinog"},{"issue":"3","key":"933_CR26","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.ccr.2012.02.008","volume":"21","author":"Tomoya Yamaguchi","year":"2012","unstructured":"Yamaguchi T, Yanagisawa K, Sugiyama R, Hosono Y, Shimada Y, Arima C, et al. NKX2\u20131\/TITF1\/TTF-1-Induced ROR1 Is Required to Sustain EGFR Survival Signaling in Lung Adenocarcinoma. Cancer Cell. 2012;21(3):348\u201361.","journal-title":"Cancer Cell"},{"issue":"8","key":"933_CR27","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.1073\/pnas.0712148105","volume":"105","author":"T Fukuda","year":"2008","unstructured":"Fukuda T, Chen L, Endo T, Tang L, Lu D, Castro JE, et al. Antisera induced by infusions of autologous Ad-CD154-leukemia B cells identify ROR1 as an oncofetal antigen and receptor for Wnt5a. Proc Natl Acad Sci. 2008;105(8):3047\u201352.","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"933_CR28","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1172\/JCI83535","volume":"126","author":"J Yu","year":"2016","unstructured":"Yu J, Chen L, Cui B, Ii GFW, Shen Z, Wu R, et al. Wnt5a induces ROR1 \/ ROR2 heterooligomerization to enhance leukemia chemotaxis and proliferation. J Clin Invest. 2016;126(2):585\u201398.","journal-title":"J Clin Invest"},{"issue":"7","key":"933_CR29","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1046\/j.1365-2443.2003.00662.x","volume":"8","author":"I Oishi","year":"2003","unstructured":"Oishi I, Suzuki H, Onishi N, Takada R, Kani S, Shibuya H, et al. The receptor tyrosine kinase Ror2 is involved in non-canonical Wnt5a \/ JNK signalling pathway. Genes Cells. 2003;8(7):645\u201354.","journal-title":"Genes Cells"},{"issue":"6932","key":"933_CR30","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/nature01522","volume":"422","author":"S Yoshikawa","year":"2003","unstructured":"Yoshikawa S, McKinnon RD, Kokel M, Thomas JB. Wnt-mediated axon guidance via the Drosophila derailed receptor. Nature. 2003;422(6932):583\u20138.","journal-title":"Nature"},{"issue":"4","key":"933_CR31","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.cell.2015.07.013","volume":"162","author":"HW Park","year":"2015","unstructured":"Park HW, Kim YC, Yu B, Moroishi T, Mo JS, Plouffe SW, et al. Alternative Wnt signaling activates YAP\/TAZ. Cell. 2015;162(4):780\u201394.","journal-title":"Cell"},{"issue":"5","key":"933_CR32","first-page":"132","volume":"24","author":"WT O\u2019Neal","year":"2014","unstructured":"O\u2019Neal WT, Griffin WF, Kent SD, Faiz F, Hodges J, Vuncannon J, et al. Deletion of the EphA2 receptor exacerbates myocardial injury and the progression of ischemic cardiomyopathy. Front Physiol. 2014;24(5):132.","journal-title":"Front Physiol"},{"issue":"Pt 7","key":"933_CR33","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1113\/jphysiol.2010.202366","volume":"589","author":"JL Dries","year":"2011","unstructured":"Dries JL, Kent SD, Virag JAI. Intramyocardial administration of chimeric ephrinA1-Fc promotes tissue salvage following myocardial infarction in mice. J Physiol. 2011;589(Pt 7):1725\u201340.","journal-title":"J Physiol"},{"issue":"1-2","key":"933_CR34","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0925-4773(01)00383-5","volume":"105","author":"Takeru Matsuda","year":"2001","unstructured":"Matsuda T, Nomi M, Ikeya M, Kani S, Oishi I, Terashima T, et al. Expression of the receptor tyrosine kinase genes, Ror1 and Ror2, during mouse development. Mech Dev. 2001;105(1-2):153\u20136.","journal-title":"Mechanisms of Development"},{"issue":"10","key":"933_CR35","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1101\/gad.1306705","volume":"19","author":"FB Engel","year":"2005","unstructured":"Engel FB, Schebesta M, Duong MT, Lu G, Ren S, Madwed JB, et al. p38 MAP kinase inhibition enables proliferation of adult mammalian cardiomyocytes. Genes Dev. 2005;19(10):1175\u201387.","journal-title":"Genes Dev"},{"issue":"42","key":"933_CR36","doi-asserted-by":"publisher","first-page":"15546","DOI":"10.1073\/pnas.0607382103","volume":"103","author":"FB Engel","year":"2006","unstructured":"Engel FB, Hsieh PCH, Lee RT, Keating MT. FGF1\/p38 MAP kinase inhibitor therapy induces cardiomyocyte mitosis, reduces scarring, and rescues function after myocardial infarction. Proc Natl Acad Sci. 2006;103(42):15546\u201351.","journal-title":"Proc Natl Acad Sci"},{"issue":"S1","key":"933_CR37","doi-asserted-by":"publisher","first-page":"S167","DOI":"10.1016\/j.clml.2015.02.010","volume":"15","author":"MY Choi","year":"2015","unstructured":"Choi MY, Ii GFW, Wu CCN, Cui B, Lao F, Sadarangani A, et al. Pre-clinical specificity and safety of UC-961, a first-in-class monoclonal antibody targeting ROR1. Clin Lymphoma Myeloma Leuk. 2015;15(S1):S167\u20139.","journal-title":"Clin Lymphoma Myeloma Leuk"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-018-0933-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12872-018-0933-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-018-0933-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T15:59:43Z","timestamp":1720713583000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-018-0933-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,20]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["933"],"URL":"https:\/\/doi.org\/10.1186\/s12872-018-0933-y","relation":{},"ISSN":["1471-2261"],"issn-type":[{"type":"electronic","value":"1471-2261"}],"subject":[],"published":{"date-parts":[[2018,10,20]]},"assertion":[{"value":"29 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Animal experiments were approved by the Laboratory Animal Care and Use Committee of the State Provincial Office of Southern Finland (license number: ESAVI\/1167\/04.10.03\/2011).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"JH is employed by and has ownership interest in Abomics Ltd. ML is employed by Medisapiens Ltd. KE has ownership interest in and is a board member of Abomics Ltd., and has ownership interest in Orion and Roche. IP, AJ, CS and TS have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"196"}}